How Viking Therapeutics Stock Could 30x
Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its midstage weight-loss candidate, VK2735.
The lowdown is that VK2735 could be a top three weight-loss medication in terms of sales, according to some analyst estimates. That's a potentially incredible opportunity for risk-tolerant investors.
Image Source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Aktie
54,02 €
-0,26 %
Die Community sieht Viking Therapeutics Inc leicht positiv: Mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 100 € für Viking Therapeutics Inc bedeutet eine deutliche Steigerung von über 50% gegenüber dem aktuellen Kurs von 54.02 €.
